Reaction
Pancreatic Neoplasm reporting signals
As of the last recalculation, Pancreatic Neoplasm appears in 1,220 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is PANCRELIPASE (PRR 46.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pancrelipase | 96 | 46.0 | 46.1 |
| Sitagliptin And Metformin Hydrochloride | 33 | 26.8 | 26.8 |
| Octreotide Acetate | 46 | 26.6 | 26.6 |
| Liraglutide | 42 | 15.0 | 15.0 |
| Indapamide | 14 | 13.5 | 13.5 |
| Valsartan Oral | 39 | 12.6 | 12.6 |
| Exenatide | 31 | 10.3 | 10.3 |
| Sitagliptin | 40 | 9.8 | 9.8 |
| Everolimus | 26 | 8.9 | 8.9 |
| Polatuzumab Vedotin | 4 | 7.0 | 7.0 |